60+ Should Get Hard Core About Longevity Strategies

When you are 60 or older and you believe that aging reversal is feasible then it is time to get serious about food, diet, intermittent fasting, and the current best treatments that might improve the odds of surviving until aging reversal is available.

There are events like raadfest in San Diego October 6-9, 2022.

Undoing Aging 2022 in Germany was canceled due to COVID travel restrictions.

Forever Healthy has online meetups and provides online information for the best current aging treatments.

Forever Healthy has Longevity Strategies and practical guides and risk-benefit analysis for all treatments and approaches.

Adopting the current best practices for longevity and signing up for cryonics are actually practical approaches that are rational unemotional choices while looking at the odds while factoring in changing technology.

Promising Rejuvenation Therapies per Forever Healthy

​​Geroprotectors

Existing compounds that slow our aging process to some extent or at least significantly lower our probability to suffer from age-related diseases.
Metformin
Berberine
Selegiline
DMAE & Centrophenoxine

Compensatory Treatments

Therapies that do not address the root causes of our aging process but rather compensate for the effects that it has on our body.
Male & female steroid hormone restoration
NAD+ restoration
Young plasma infusions
Young plasma exosomes
Immune support with dendritic & NK cells

Molecular & Cellular Repair

Therapies that address the root causes or near-root causes of our aging process and repair damage on a molecular or cellular level.
Endothelial repair using MitoQ
Cellular membrane repair using IV & oral essential phospholipids
Arterial & capillary decalcification using IV EDTA
First generation senolytics: Dasatinib, Quercetin, Fisetin, Piperloungime, Azithromycin
Localized and systemic application of mesenchymal and amniotic stem cells
Thymus regeneration

Forever Healthy’s “Rejuvenation Now” initiative that seeks to continuously identify potential rejuvenation therapies and systematically evaluate their risks, benefits, and associated therapeutic protocols to create transparency.

Currently available Risk-Benefit Analyses at Forever Healthy

NEW: Phospholipid Therapy

Phospholipids are an important structural component of cell and organelle membranes and play a role in many cell signaling pathways. Membranes incur oxidative damage over time and in several disease conditions. Oral and/or i.v. supplementation of phospholipids (particularly phosphatidylcholine), is hypothesized to repair this damage by replacement of oxidized membrane phospholipids with “healthy” phospholipids, thus restoring or maintaining membrane integrity and function.

Dasatinib and Quercetin Senolytic Therapy

Dasatinib is a well-established medication used in the treatment of cancer. Quercetin is a flavonoid found in many plants and foods that is often used as a supplement. It is supposed that intermittent dosing of D+Q leads to the elimination of senescent cells in humans and by doing so, has the potential to prevent, delay, or alleviate multiple age-related diseases and increase the healthy lifespan.

Vascular Rejuvenation using EDTA

EDTA chelation therapy is the use of EDTA, a synthetic amino acid, to remove unwanted metals from the body. Observed “side effects” include rejuvenation of the cardiovascular system and a substantial reduction of adverse cardiovascular events such as heart attack and stroke. Proposed mechanisms include the stabilization and reduction of atherosclerotic plaque, prevention of epigenetic changes, and stabilization of membranes.

Skin Rejuvenation by Low-Level Light Therapy

Low-level light therapy or photobiomodulation is the use of low-energy light at a particular wavelength to influence cellular processes. Targeting the skin, it is supposed to lead to a more youthful appearance through increased collagen and elastin production, and a reduction in age spots and wrinkles.

Fisetin Senolytic Therapy

Fisetin is a flavonoid found in many types of fruits and vegetables that is readily available over the counter as a supplement. Used intermittently at high doses it is supposed to act as a senolytic agent to remove senescent cells presenting an easily accessible, inexpensive therapeutic option.

NAD+ Restoration Therapy

NAD+ is a nucleotide found in all living cells that plays an important role in energy metabolism. Levels may decline markedly with age and restoring them to a youthful state using various oral precursors, transdermal patches or IVs is believed to have beneficial effects on health and longevity.

Changing Odds As We Age

Hong Kong is one of the countries or regions with the highest life expectancy. In 2014, the life expectancy was 83.5 for men and 89.2 for women. Life expectancy for all countries has dropped in the last year or two because of the COVID pandemic. Life expectancy is a calculation based upon the age of people who are dying in the current year and assuming that it will repeat going into the future.

When people are around 39 years old they have a 0.05% chance of dying before they turn 40.
When men are about 55-60 and when women are about 60 to 66 they have a 0.5% chance of dying before they get one year older.

Men in Hong Kong have a 4% chance of dying in their 50s, while women in Hong Kong have a little less than a 2.3% chance of dying in their 50s.
Men in Hong Kong have a 10% chance of dying in their 60s, while women in Hong Kong have a little less than a 5% chance of dying in their 60s.
Men in Hong Kong have a 25% chance of dying in their 70s, while women in Hong Kong have a little less than a 13.5% chance of dying in their 70s.
Men in Hong Kong have a 57% chance of dying in their 80s, while women in Hong Kong have a little less than a 38.5% chance of dying in their 80s.

When men in Hong Kong are 60 they have an expected 24 years of further life. Women in Hong Kong who are 60 have an expected 29 years of further life.

Once anyone is past the life expectancy from birth number (80 for some people or 90 for others) then the chance of them dying in the next year gets close to 10% and then rapidly moves past 10% towards 20-30% and then goes flat at 30-40%.

Making it ten years past the life expectancy is beating the odds. Only 27% of the men in Hong Kong who make it to 83.5 would be expected to make it to 94. Only 21% of the women in Hong Kong who make it to 89 would be expected to make it to 99.

Only about one in 500 people make it from 100 to 110. There are currently about 300 and 450 living supercentenarians (110 or older) in the world. There were about 1.8 billion people in 1912. 1 in 4.5 million people made it to an official recorded and registered age over 110. There are about 573000 centenarians now. 1200 to 1500 of the current centenarians should make to 110+.

A 60-year-old Hong Kong man who expects radical life extension or aging reversal to be developed and available for you within 20 years then men have a 35% chance of needing cryonics to freeze your body or head for revival. Hong Kong people have the longest life expectancy so the odds would be worse for pretty much everyone else.

A 60-year-old Hong Kong woman who expects radical life extension or aging reversal to be developed and available for you within 20 years then men have a 19% chance of needing cryonics to freeze your body or head for revival. Hong Kong people have the longest life expectancy so the odds would be worse for pretty much everyone else.

Those who are 70 or older need and believe that aging reversal and advanced antiaging is possible and perhaps molecular nanotechnology eventually has a 5% or more chance then they should sign up for cryonics. Alcor provides cryonics services.

SOURCES- Forever Healthy, Raadfest, SENS, Hong Kong Actuarial tables
Written by Brian Wang, Nextbigfuture.com

Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.

Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.

A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts.  He is open to public speaking and advising engagements.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Peach, A321LR operated from 28th Kansai to Sendai is the first flight thumbnail

Peach, A321LR operated from 28th Kansai to Sendai is the first flight

 ピーチ・アビエーション(APJ/MM)は12月27日、エアバスA321LRの初号機(登録記号JA902P)の就航をさらに前倒しし、28日の関西発仙台行きMM133便から投入すると発表した。年末年始期間に悪天候が生じた際も、機材を柔軟に運用できる体制にするためだという。 *初便就航当日の記事はこちら。ピーチのA321LR=21年12月19日 PHOTO: Tadayuki YOSHIKAWA/Aviation Wire  運航スケジュールは28日から2022年1月11日までの予定。仙台行きMM133便は関西空港を午前9時25分に出発し、午前10時45分に着く。その後は仙台午前11時30分発の那覇行きMM421便、那覇午後4時5分発の関西行きMM216便に投入する。また、これら3便以外にも機材繰りなどの関係で投入する可能性があるとしている。  A321LRの就航セレモニーは、当初の予定通り1月18日に開催。関西発那覇行きMM211便の出発前に式典を開く。ピーチは「1月18日の便にご予約いただいたお客様には大変心苦しく、お詫びいたします」とコメントしている。  A321LRはA320neoの胴体を約6.9メートル伸ばしたA321neoの航続距離延長型で、LRは「Long Range(ロングレンジ)」の略。ピーチはA321LRの導入をコロナ前の2018年7月に発表した。座席数は1クラス218席で、現在運航しているA320ceo(従来型A320、1クラス180席)や、発展型で2020年10月に就航した低燃費・低騒音の新型エンジンを搭載するA320neo(1クラス188席)よりも多くの乗客を運べる。  国内の航空会社でA321LRを導入するのはピーチが初めて。既存機よりもシートピッチが広くなり、充電用USB端子も備える。 運航スケジュール(12月28日から1月11日まで) MM133 関西(09:25)→仙台(10:45) MM421 仙台(11:30)→那覇(14:55) MM216 那覇(16:05)→関西(18:00) 1月18日の就航セレモニー実施便 MM211 関西(07:15)→那覇(09:45) 関連リンクピーチ・アビエーション 初便就航 ・ピーチ、A321LR就航 初便は関空発仙台行き、国内初導入(21年12月28日) 関空に到着 ・ピーチ、A321LRが関空到着 国内初導入、1月に就航前倒し(21年12月20日) A321LR ・ピーチ、A321LRをALCからリース導入 2月就航へ(21年12月10日) ・ピーチのA321LR、22年2月就航へ 関西ー那覇・札幌(21年11月29日) ・ピーチ、A320neoを9月初受領 A321LRは国内幹線投入も(20年6月19日) ・ピーチ、A320neoとA321LR用エンジンにCFM製LEAP-1A採用 20年度から(19年6月17日) ・ピーチ、A321LRを20年度導入へ 井上CEO「片道7時間程度」(18年7月17日) A320neo ・ピーチ、A320neo就航 燃費2割改善、リクライニング済みシート(20年10月25日) ・ピーチ、A320neoお披露目 座席間隔そのまま8席増、燃費2割改善(20年10月16日) ・国内初採用エンジンLEAP 写真特集・ピーチA320neo初号機(20年10月24日)
Read More
Launch timeline for Atlas 5’s mission with Landsat 9 thumbnail

Launch timeline for Atlas 5’s mission with Landsat 9

A United Launch Atlas 5 rocket is set for launch with the Landsat 9 satellite, a joint project between NASA and the U.S. Geological Survey, and four small CubeSat rideshare payloads. The 194-foot-tall (59-meter) rocket, propelled by an RD-180 main engine, is set for liftoff during a 30-minute launch window Monday that opens at 11:12…
Read More
Earth’s Safe Planetary Boundary for Pollutants – Including Plastics – Exceeded thumbnail

Earth’s Safe Planetary Boundary for Pollutants – Including Plastics – Exceeded

The updated Planetary Boundaries framework (2022) showing 5 boundaries transgressed, now including “novel entities.” Credit: Stockholm Resilience Centre/Azote First assessment published of planetary boundary related to “novel entities.” For the first time, an international team of researchers has assessed the impact on the stability of the Earth system of the cocktail of synthetic chemicals and…
Read More
Victor Vescovo Dives to the Bottom of the Atacama Trench thumbnail

Victor Vescovo Dives to the Bottom of the Atacama Trench

Underwater explorer Victor Vescovo recently dove to the deepest part of the Atacama Trench off the Chilean coast. Vescovo did the dive alongside Dr. Osvaldo Ulloa, Director of Chile’s Instituto Milenio de Oceanografia (IMO). The maximum depth recorded at the Atacama Trench’s lowest point was approximately 8,069 meters (26,473 feet). The new deepest point identified…
Read More
Index Of News